GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMF) » Definitions » Interest Expense

Shanghai Pharmaceuticals Holding Co (Shanghai Pharmaceuticals Holding Co) Interest Expense : $-228 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Shanghai Pharmaceuticals Holding Co's interest expense for the three months ended in Mar. 2024 was $ -65 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-228 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Shanghai Pharmaceuticals Holding Co's Operating Income for the three months ended in Mar. 2024 was $ 375 Mil. Shanghai Pharmaceuticals Holding Co's Interest Expense for the three months ended in Mar. 2024 was $ -65 Mil. Shanghai Pharmaceuticals Holding Co's Interest Coverage for the quarter that ended in Mar. 2024 was 5.73. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pharmaceuticals Holding Co Interest Expense Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co Interest Expense Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -170.85 -173.01 -41.47 -202.49 -232.98

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -71.40 -50.08 -83.68 -28.33 -65.50

Shanghai Pharmaceuticals Holding Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-228 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Shanghai Pharmaceuticals Holding Co's Interest Expense for the three months ended in Mar. 2024 was $-65 Mil. Its Operating Income for the three months ended in Mar. 2024 was $375 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $1,130 Mil.

Shanghai Pharmaceuticals Holding Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*375.224/-65.496
=5.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Shanghai Pharmaceuticals Holding Co (Shanghai Pharmaceuticals Holding Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (OTCPK:SHPMF) » Definitions » Interest Expense
Comparable Companies
SHSE:600511 SZSE:000028 SHSE:600056 SHSE:600739 SZSE:000950 SHSE:603368 SZSE:002589 SZSE:002551 MCK COR CAH HSIC HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO TSE:9987
Traded in Other Exchanges
SHPMY:USA 02607:Hong Kong S1R:Germany S1R:Germany 601607:China
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Website
https://www.sphchina.com
Shanghai Pharmaceuticals Holding is a vertically integrated Chinese healthcare company that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the second-largest distributor by revenue and has a strong distribution presence in Eastern China.